BackPOINT Biopharma Global Overview

POINT Biopharma Global Receivables

Latest receivables for PNT: $9.4M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$9.39M

Peer trimmed avg / median

Loading

POINT Biopharma Global Receivables History

Loading

POINT Biopharma Global vs. peers: Receivables Comparison

Loading

POINT Biopharma Global Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

POINT Biopharma Global (PNT) FAQ

POINT Biopharma Global (PNT) currently reports a receivables of $9.4M as of September 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore POINT Biopharma Global's receivables history and peer comparisons.

POINT Biopharma Global's receivables changed from $0 to $9.4M (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

POINT Biopharma Global reported $9.4M in receivables as of September 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $9.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for POINT Biopharma Global, and consider following PNT for alerts when major investors trade the stock.

POINT Biopharma Global is classified in the Healthcare sector. On receivables, it currently shows $9.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PNT with unrelated industries.